February 24, 2012in IP, Pharmaceutical Drugs1by Editor587 WHO Resolution Intended to Address Global Counterfeit Drug Market On January 21, the WHO 130th WHO Executive Board (EB) adopted a resolution for agenda item 6.13 “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” [SFFC]. The resolution is intended to address the growing prevalence…
